Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Duration of Bupivacaine Spinal Block in Orthopedic Procedures With and Without Epinephrine Wash

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years of age or older~* Patients scheduled for total hip or knee replacement~Exclusion Criteria:~* Patients taking anticoagulation~* Infection at or near the intended needle insertion site~* Patients with sacral decubitus ulcer at or near the intended needle insertion site aortic stenosis~* Complex spine anatomy~* ASA class greater than III~* Failed SAB as determined by the staff anesthesiologist

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Bupivacaine Only (Type: PLACEBO_COMPARATOR): The bupivacaine only group will receive bupivacaine 0.5% 3cc plus sterile saline 0.1cc.
- EPI25 group (Type: ACTIVE_COMPARATOR): The EPI25 group will receive bupivacaine 0.5% 3cc, epinephrine 1:1000 0.025cc, and sterile saline 0.075cc.
- EPI50 group (Type: ACTIVE_COMPARATOR): The EPI50 group will receive bupivacaine 0.5% 3cc, epinephrine 1:1000 0.05cc, and sterile saline 0.05cc.
- EPI75 group (Type: ACTIVE_COMPARATOR): The EPI75 group will receive bupivacaine 0.5% 3cc, epinephrine 1:1000 0.075 cc, and sterile saline 0.025%.
- EPI100 group (Type: ACTIVE_COMPARATOR): The EPI100 group will receive bupivacaine 0.5% 3cc, and epinephrine 1:1000 0.1cc

Based on this trial design, predict the completion outcome and termination type (if applicable).